GlassScriptPhysician profile
Anupam Basuray
NPI 1659536894
$5,745.91
in general payments reported to CMS, 2019-2025
17 companies · $176 in 2025
The $176 reported for 2025 was less than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $727 · 2020: $1,594 · 2021: $629 · 2022: $836 · 2023: $1,275 · 2024: $508 · 2025: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,810 · Education: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,809.96 |
| Education | $149.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,078.35 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Pfizer INC. | $1,575.00 | 2020 | |
| Cvrx, INC. | $409.62 | 2022-2023 | Barostim Neo System |
| Actelion Pharmaceuticals US, INC. | $346.73 | 2021-2024 | Opsumit, Uptravi |
| Abiomed | $323.34 | 2021-2024 | Impella |
| E.R. Squibb & Sons, L.L.C. | $177.34 | 2022-2023 | Eliquis, Camzyos |
| Astellas Pharma US INC | $149.50 | 2023 | |
| W. L. Gore & Associates, INC. | $136.38 | 2021 | |
| United Therapeutics Corporation | $132.32 | 2023 | Orenitram, Tyvaso, Remodulin |
| Boston Scientific Corporation | $114.74 | 2019 | |
| Medtronic, INC. | $105.25 | 2021-2023 | Reveal Linq |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $58.13 | 2022-2024 | Lifevest |
| Kestra Medical Technology Services, INC. | $44.66 | 2024 | Assure Wcd |
| Davol INC. | $36.97 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $31.96 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $25.62 | 2023 | Optimizer |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anupam Basuray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.